Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 780

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

Open access
Pai, Sung-Yun, Logan, Brent R., Griffith, Linda M., Buckley, Rebecca H., Parrott, Roberta E., Dvorak, Christopher C., Kapoor, Neena, Hanson, Imelda C., Filipovich, Alexandra H., Jyonouchi, Soma, Sullivan, Kathleen E., Small, Trudy N., Burroughs, Lauri, Skoda-Smith, Suzanne, Haight, Ann E., Grizzle, Audrey, Pulsipher, Michael A., Chan, Ka Wah, Fuleihan, Ramsay L., Haddad, Elie, Loechelt, Brett, Aquino, Victor M., Gillio, Alfred, Davis, Jeffrey, Knutsen, Alan, Smith, Angela R., Moore, Theodore B., Schroeder, Marlis L., Goldman, Frederick D., Connelly, James A., Porteus, Matthew H., Xiang, Qun, Shearer, William T., Fleisher, Thomas A., Kohn, Donald B., Puck, Jennifer M., Notarangelo, Luigi D., Cowan, Morton J., O'Reilly, Richard J.·2014·New England Journal of Medicine

Abstract

BACKGROUND: The Primary Immune Deficiency Treatment Consortium was formed to analyze the results of hematopoietic-cell transplantation in children with severe combined immunodeficiency (SCID) and other primary immunodeficiencies. Factors associated with a good transplantation outcome need to be identified in order to design safer and more effective curative therapy, particularly for children with SCID diagnosed at birth. METHODS: We collected data retrospectively from 240 infants with SCID who had received transplants at 25 centers during a 10-year period (2000 through 2009). RESULTS: Survival at 5 years, freedom from immunoglobulin substitution, and CD3+ T-cell and IgA recovery were more likely among recipients of grafts from matched sibling donors than among recipients of grafts from alternative donors. However, the survival rate was high regardless of donor type among infants who received transplants at 3.5 months of age or younger (94%) and among older infants without prior infection (90%) or with infection that had resolved (82%). Among actively infected infants without a matched sibling donor, survival was best among recipients of haploidentical T-cell-depleted transplants in the absence of any pretransplantation conditioning. Among survivors, reduced-intensity or myeloablative pretransplantation conditioning was associated with an increased likelihood of a CD3+ T-cell count of more than 1000 per cubic millimeter, freedom from immunoglobulin substitution, and IgA recovery but did not significantly affect CD4+ T-cell recovery or recovery of phytohemagglutinin-induced T-cell proliferation. The genetic subtype of SCID affected the quality of CD3+ T-cell recovery but not survival. CONCLUSIONS: Transplants from donors other than matched siblings were associated with excellent survival among infants with SCID identified before the onset of infection. All available graft sources are expected to lead to excellent survival among asymptomatic infants. (Funded by the National Institute of Allergy and Infectious Diseases and others.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1401177

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 780

Metadata

Authors
Pai, S.-Y., Logan, B. R., Griffith, L. M., Buckley, R. H., Parrott, R. E., Dvorak, C. C., Kapoor, N., Hanson, I. C., Filipovich, A. H., Jyonouchi, S., Sullivan, K. E., Small, T. N., Burroughs, L., Skoda-Smith, S., Haight, A. E., Grizzle, A., Pulsipher, M. A., Chan, K. W., Fuleihan, R. L., Haddad, E., Loechelt, B., Aquino, V. M., Gillio, A., Davis, J., Knutsen, A., Smith, A. R., Moore, T. B., Schroeder, M. L., Goldman, F. D., Connelly, J. A., Porteus, M. H., Xiang, Q., Shearer, W. T., Fleisher, T. A., Kohn, D. B., Puck, J. M., Notarangelo, L. D., Cowan, M. J., & O'Reilly, R. J.
Venue
New England Journal of Medicine
Published
2014-07-31
Volume
371
Issue
5
Pages
434-446
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2122153475
Cited by
780
References
33
FWCI
26.58
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009. https://app.cochat.ai/papers/10.1056/nejmoa1401177
The paper
Pai, S.-Y., Logan, B. R., Griffith, L. M., Buckley, R. H., Parrott, R. E., Dvorak, C. C., Kapoor, N., Hanson, I. C., Filipovich, A. H., Jyonouchi, S., Sullivan, K. E., Small, T. N., Burroughs, L., Skoda-Smith, S., Haight, A. E., Grizzle, A., Pulsipher, M. A., Chan, K. W., Fuleihan, R. L., . . . O'Reilly, R. J. (2014). Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1401177

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.